Lasa Supergenerics Limited has informed the Exchange regarding a press release dated April 24, 2025, titled "Press Release titled Lasa Supergenerics Limited Announces the Expansion of Manufacturing Capacity of API Albendazole to meet the Growing Demands issued by the Company. ".